What is ORAGRAFIN SODIUM used for?

ORAGRAFIN SODIUM is an FDA-approved medication. See full prescribing information for approved uses.

Is ORAGRAFIN SODIUM FDA approved?

Yes, ORAGRAFIN SODIUM is FDA approved (first approved 1962-06-25) and manufactured by BRACCO.

Who makes ORAGRAFIN SODIUM?

ORAGRAFIN SODIUM is manufactured by BRACCO.

Data updated: Mar 10, 2026

ORAGRAFIN SODIUM

IPODATE SODIUM

Approved 1962-06-25

Jump to: Indications Approvals Trials Competitors Safety Patents

Indication

Phase 3 Trials

Priority Reviews

Years on Market

Details

Status: Discontinued
First Approved: 1962-06-25
Routes: ORAL
Dosage Forms: CAPSULE

Companies

BRACCO

Active Ingredient: IPODATE SODIUM

ORAGRAFIN SODIUM Approval History

Loading approval history...

What ORAGRAFIN SODIUM Treats

1 FDA approvals

Originally approved for its first indication in 1962 .

Other (1)

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Understanding FDA Approval Types

Count	Type	What it means
-	ORIG	Original approval - drug first enters market
-	SUPPL - Efficacy	New indication (new disease/condition approved)
-	SUPPL - Labeling	Label text changes (warnings, dosing updates)
-	SUPPL - Manufacturing	Production changes (new facility)
-	SUPPL - Chemistry	Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ORAGRAFIN SODIUM FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA012967 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.